Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine effects on brain function in adults with ADHD
ACTRN12610000432011Phase 4Not yet recruiting
- Sponsor
- The University of Queensland
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Atomoxetine with Placebo (2 arms). Primary endpoints: Continuous Temporal Expectancy Task, Stop Signal Task and 1 more. Planned start Jun 2010; status: not yet recruiting.
02
Drugs
atomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on ACTRN12610000432011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000432011.